BioAffinity Technologies

About:

BioAffinity Technologies is a cancer diagnostics company that develops non-invasive, early-stage diagnostics to detect cancer and diseases.

Website: http://www.bioaffinitytech.com

Twitter/X: bioaffinity

Description:

BioAffinity Technologies applies experience, intelligence and creativity to the global fight against cancer, the company addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. The company uses technology that preferentially targets cancer cells and cell types indicative of a sick condition to produce exclusive noninvasive diagnostic tests and cancer therapies. The business is engaged in the development of technologies that, in the future, will be able to diagnose, track, and treat a variety of cancers, including lung ailments. BioAffinity Technologies was established in 2014 in San Antonio, Texas.

Total Funding Amount:

$31.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Antonio, Texas, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)bioaffinitytech.com

Founders:

Steven Cantor

Number of Employees:

11-50

Last Funding Date:

2024-10-18

IPO Status:

Public

Industries:

© 2025 bioDAO.ai